Wave Life Sciences Ltd. (NASDAQ:WVE) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? [Yahoo! Finance]
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: Yahoo! Finance
Revenues were in line with expectations, at US$20m, while statutory losses ballooned to US$0.25 per share. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year. See our latest analysis for Wave Life Sciences Taking into account the latest results, the current consensus, from the seven analysts covering Wave Life Sciences, is for revenues of US$72.1m in 2024. This implies a painful 35% reduction in Wave Life Sciences' revenue over the past 12 months. Losses are forecast to balloon 68% to US$0.99 per share. Before this latest report, the consensus had been expecting revenues of US$62.5m and US$0.88 per share in losses. Ergo, there's been a clear change in sentiment, with the analysts lifting this year's revenue estimates, while a
Show less
Read more
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- Wave Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $10.00 price target on the stock.MarketBeat
- Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular DystrophyGlobeNewswire
- Wave Life Sciences Ltd. (WVE) Q2 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business UpdateGlobeNewswire
WVE
Earnings
- 8/8/24 - Miss
WVE
Sec Filings
- 8/23/24 - Form 4
- 8/21/24 - Form 144
- 8/14/24 - Form 4
- WVE's page on the SEC website